Vahid Monfared , Kiyana Talati Far , Farhad Vahid , Adel Salehian , Faezeh Akbarpoor , Zeinab Nikniaz , Zeinab Faghfoori
{"title":"The effect of flaxseed on lipid profile in healthy individuals: A systematic review and dose-response meta-analysis of clinical trials","authors":"Vahid Monfared , Kiyana Talati Far , Farhad Vahid , Adel Salehian , Faezeh Akbarpoor , Zeinab Nikniaz , Zeinab Faghfoori","doi":"10.1016/j.aimed.2024.08.006","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Findings on the effects of flaxseed on the lipid profile in healthy individuals are conflicting. The current comprehensive systematic review and meta-analysis aimed to summarize available evidence in this regard.</p></div><div><h3>Methods</h3><p>After a systematic search in the online databases, we included the randomized controlled trials (RCTs) investigating the effect of flaxseed on the lipid profile [total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), Apolipoprotein -A (apo-A) and Apolipoprotein -B (apo-B)] in healthy individuals.</p></div><div><h3>Results</h3><p>Altogether, 16 studies with a total sample size of 1000 were included in the analysis. Combining 17 effect sizes from 16 RCTs, we found a significant lowering effect of flaxseed on serum levels of TG (weighted mean difference (WMD): < 0.001, 95 % CI: −0.05–0.05 mmol/L; p = 0.996), TC (WMD: 0.23 mmol/l; 95 % CI: −0.34 to −0.13; p &l; 0.001), LDL-C (WMD): −0.15 mmol/l; 95 % CI: −0.26 to −0.05; p = 0.003), HDL-C (WMD): −0.05 mmol/l; 95 % CI: −0.09 to −0.02; p = 0.001), apo-A (WMD): 0.16 g/l; 95 % CI: −0.26–0.58; p= 0.465) and apo-B (WMD): −0.06 g/l; 95 % CI: −0.15–0.02; p = 0.131).</p></div><div><h3>Conclusion</h3><p>The present study demonstrates the beneficial effects of flaxseed on TC, HDL-C, and LDL-C in healthy people.</p></div>","PeriodicalId":7343,"journal":{"name":"Advances in integrative medicine","volume":"11 3","pages":"Pages 123-132"},"PeriodicalIF":1.7000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in integrative medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2212958824000831","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Findings on the effects of flaxseed on the lipid profile in healthy individuals are conflicting. The current comprehensive systematic review and meta-analysis aimed to summarize available evidence in this regard.
Methods
After a systematic search in the online databases, we included the randomized controlled trials (RCTs) investigating the effect of flaxseed on the lipid profile [total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride (TG), Apolipoprotein -A (apo-A) and Apolipoprotein -B (apo-B)] in healthy individuals.
Results
Altogether, 16 studies with a total sample size of 1000 were included in the analysis. Combining 17 effect sizes from 16 RCTs, we found a significant lowering effect of flaxseed on serum levels of TG (weighted mean difference (WMD): < 0.001, 95 % CI: −0.05–0.05 mmol/L; p = 0.996), TC (WMD: 0.23 mmol/l; 95 % CI: −0.34 to −0.13; p &l; 0.001), LDL-C (WMD): −0.15 mmol/l; 95 % CI: −0.26 to −0.05; p = 0.003), HDL-C (WMD): −0.05 mmol/l; 95 % CI: −0.09 to −0.02; p = 0.001), apo-A (WMD): 0.16 g/l; 95 % CI: −0.26–0.58; p= 0.465) and apo-B (WMD): −0.06 g/l; 95 % CI: −0.15–0.02; p = 0.131).
Conclusion
The present study demonstrates the beneficial effects of flaxseed on TC, HDL-C, and LDL-C in healthy people.
期刊介绍:
Advances in Integrative Medicine (AIMED) is an international peer-reviewed, evidence-based research and review journal that is multi-disciplinary within the fields of Integrative and Complementary Medicine. The journal focuses on rigorous quantitative and qualitative research including systematic reviews, clinical trials and surveys, whilst also welcoming medical hypotheses and clinically-relevant articles and case studies disclosing practical learning tools for the consulting practitioner. By promoting research and practice excellence in the field, and cross collaboration between relevant practitioner groups and associations, the journal aims to advance the practice of IM, identify areas for future research, and improve patient health outcomes. International networking is encouraged through clinical innovation, the establishment of best practice and by providing opportunities for cooperation between organisations and communities.